| Similar Articles |
|---|
 |
Chemistry World
May 7, 2013
Phillip Broadwith |
Buy Viagra online - direct from the manufacturer Pharmaceutical giant Pfizer is cutting out the pharmacist middle-man by setting up a website for Viagra (sildenafil citrate) sales.   |
The Motley Fool
August 16, 2011
Brian Orelli |
Keeping Those Little Blue Pill Sales Up Pfizer wins a patent lawsuit for Viagra. |
The Motley Fool
November 21, 2008
Brian Orelli |
Viagra Stays Behind the Counter All puns about soft sales and wishing something would go up in this market have been removed from this article. |
The Motley Fool
December 10, 2010
Brian Orelli |
Was This Drug Destined for Failure? Pfizer announces that it's pulling Thelin off the market, and withdrawing the marketing application with the Food and Drug Administration, because a new side effect was discovered. |
The Motley Fool
June 11, 2010
Brian Orelli |
Pfizer and Bristol Coagulate Against Clots Let's see how apixaban does against warfarin before we break out the "blockbuster" stamp. |
The Motley Fool
August 18, 2010
Brian Orelli |
No Pain Here as Jazz Shares Rocket Investors are all jazzed up about Jazz Pharmaceuticals |
BusinessWeek
July 8, 2010
Simeon Bennett |
Pfizer: Civil Suits for Drug Counterfeiters Pfizer's new tactics against fake drug peddlers have allowed it to recoup more than $5 million. That's still a fraction of its lost sales. |
The Motley Fool
March 25, 2011
Brian Orelli |
Pfile Pfizer Under "Potential" Researchers reported promising finding from a clinical trial of Pfizer's new drug, CP-870,893, in pancreatic cancer patients in the most recent issue of the journal Science. |
Chemistry World
December 8, 2015
Jennifer Newton |
Pfizer to close Cambridge pain outpost Pfizer plans to shut down its Neusentis site on the outskirts of Cambridge, UK, in a move that will eliminate up to 120 jobs. |
The Motley Fool
May 25, 2011
Brian Orelli |
Satisfying Clinical Trial Straightens Up Shares VIVUS' erectile dysfunction drug avanafil works. |
Chemistry World
February 2, 2011
Andy Extance |
Pfizer to close historic UK site Most of the 2400 people employed at the Pfizer site in Sandwich, UK, will be made redundant over the next 18-24 months as the US pharma giant restructures its research operations. |
The Motley Fool
April 20, 2004
Alyce Lomax |
Pfizer's Fight First-quarter earnings give mixed messages on the drug maker's meds. |
The Motley Fool
April 26, 2011
Brian Orelli |
We Hate Your Drug. And That's a Good Thing. This one's a pain for the clinical trial participants. |
The Motley Fool
June 6, 2011
Brian Orelli |
Big Pharma Tackles Lung Cancer; Biotech Helping, Too A big underserved market. |
The Motley Fool
January 22, 2010
Brian Orelli |
Pfizer's Great Data Won't Do Much The full data from a clinical trial testing Pfizer's Sutent in pancreatic cancer was truly amazing. Unfortunately, it's not going to do very much for the stock or Pfizer's bottom line. |
The Motley Fool
May 27, 2005
Nick Baker |
Mama Always Said You'd Go Blind Urban legends aside, what do new concerns about Viagra and Cialis mean for investors? |
The Motley Fool
January 8, 2010
Brian Orelli |
Pfizer's Having a Garage Sale Rather than sending its unwanted drugs to the trash bin, the giant drugmaker is striking deals with its comrades to take them off its hands. |
The Motley Fool
May 14, 2008
Brian Lawler |
Teaching Old Drugs New Tricks Pfizer's top drugs post mixed results in recent off-label studies. |
Pharmaceutical Executive
May 1, 2006
Ron Feemster |
Teamsters v. Pfizer A New Jersey Teamsters local says Pfizer tricked them into paying for off-label Lipitor prescriptions. Do you have any questions about that? We do. |
BusinessWeek
February 28, 2005
David Kiley |
The Little Blue Pill -- And Pals -- Have The Blues Despite gargantuan ad budgets, sales are trailing expectations for all three erectile dysfunction contenders. |
AskMen.com
Joshua Levine |
Natural Alternatives To Viagra Is there an alternative to Viagra, something more "natural" like an herb or supplement? Several interesting supplements have recently come to light and may provide benefits within days to weeks. |
InternetNews
February 10, 2005
Tim Gray |
Microsoft and Pfizer After Viagra Spammers Redmond and the pharmaceutical giant team up to file lawsuits to fight selling and advertising of knock-off drugs. |
The Motley Fool
April 4, 2011
Brian Orelli |
Pfizer Tests the Breakup Waters The company announced today that it found a buyer for its Capsugel unit, which will bring in a cool $2.4 billion. |
The Motley Fool
August 12, 2010
Brian Orelli |
Pfizer: Strengths, Weaknesses, Opportunities, Threats Knowing them all makes it easier to judge an investment. |
The Motley Fool
September 2, 2010
Brian Orelli |
Pfizer Takes an Orphan Into the Fold Pfizer is likely pursuing FoldRx's pipeline and expertise in rare diseases. |
The Motley Fool
May 18, 2009
Brian Orelli |
Free Drugs! Pfizer's giving over 70 drugs away -- to people who have lost their jobs and health insurance recently and can show financial hardship. |
Chemistry World
March 2011
Bea Perks |
Editorial: At the forefront The news that most of Pfizer's 2400 employees at Sandwich, U.K. will be made redundant over the next two years was met with surprise, disappointment and anger. |
Chemistry World
April 6, 2011
Andrew Turley |
Pfizer sells capsule business for $2.4bn Investment firm Kohlberg Kravis Roberts has agreed to pay $2.4 billion in cash for the business, which it says has 'an excellent portfolio'. |
The Motley Fool
May 21, 2010
Brian Orelli |
And You Thought Biotech Was High-Risk, High-Reward Large clinical trials make cardiovascular drugs risky, but the rewards are there, too. |
The Motley Fool
January 27, 2011
Rich Smith |
What's Behind the Run-Up at Rexahn? The pharmaceutical's hot streak could soon burn up all its cash. |
The Motley Fool
February 9, 2010
Brian Orelli |
Pfizer's Slippery Slope Discount cards for drugs help Pfizer track patients' use. |
The Motley Fool
July 13, 2004
Brian Gorman |
The "Cialis Promise" Eli Lilly and Icos are offering a free trial of their drug Cialis for men who have never used it before and promise that participants not pleased with the results will receive a voucher for a competing product. |
AskMen.com
October 30, 2015
Asandra & Palubicki |
Are Erectile Dysfunction Supplements Dangerous? Here's why erectile dysfunction supplements can be extremely dangerous. |
Chemistry World
June 27, 2013
Phillip Broadwith |
Ups and downs for erectile dysfunction drugs Spedra (avanafil) aims to compete for a share of the lucrative ED market, trading on the fact that it is much faster-acting than other available drugs. |
BusinessWeek
October 27, 2003
Michael Arndt |
Is Viagra Vulnerable? Eli Lilly's Cialis lasts for 36 hours -- and a $100 million ad blitz will spread the word. |
The Motley Fool
January 29, 2010
Brian Orelli |
How to Make Billions of Dollars Without Really Trying Lackluster Alzheimer's drugs have been doing it for years. |
The Motley Fool
September 3, 2010
Brian Orelli |
Why You Just Got Hammered Celldex's decline is due to potential reasons Pfizer would send back a drug it's been working on with Celldex for over two years |
Nutra Solutions
June 1, 2005 |
Hidden Drug Costs Up to five salespeople from the same company may call on the same doctor about the same product. Drug makers spend over $7 billion on such calls each year, compared to $4 billion on direct-to-consumer advertising. |
Pharmaceutical Executive
April 1, 2006
Diane West |
Media Spend Trends: Change the Channel Drug marketers still spend lots of money. But they aim at PhRMA loopholes. |
The Motley Fool
March 4, 2011
Brian Orelli |
Pfizer's Biggest Shot at Lipitor 2.0 It might need a little help from competitors. |
The Motley Fool
September 14, 2010
Luke Timmerman |
Arena Obesity Drug Effective by "Slim Margin"; Shares Tumble The market is reacting negatively to news about the company's weight-loss drug. |
The Motley Fool
January 7, 2010
Brian Orelli |
Pfizer Strides Farther Into Generics Pfizer's new look might be just what the doctor ordered. |
AskMen.com
Joshua Levine |
I Just Can't Get It Up!: Part I There comes a time in a man's life where he must face up to the fact that his best friend will let him down. This is probably the time in a man's life where his self-esteem is most vulnerable. |
The Motley Fool
May 4, 2010
Brian Orelli |
Earnings Growth Trumps Revenue Growth, Except Here A solid quarter for Pfizer, but is there more in the tank? |
Chemistry World
June 24, 2011
Andrew Turley |
Pfizer to Keep 350 Jobs at Sandwich US drug giant Pfizer has said that it will keep 350 jobs at its site in Sandwich, UK. |
The Motley Fool
March 8, 2010
Brian Orelli |
Really? A 59% Share Price Jump for That? Justified or not, InterMune skyrockets ahead of an FDA panel meeting. |
Pharmaceutical Executive
August 1, 2011
William Looney |
Innovation at Pfizer A Q and A with Kristin Peck, the drug maker's Executive Vice President, Worldwide Business Development and Innovation. |
The Motley Fool
July 30, 2010
Anand Chokkavelu |
5 Stocks to Consider Before Buying Pfizer If you like Pfizer, you may like these five insurance and medical stocks better. |
BusinessWeek
December 18, 2006
Arlene Weintraub |
Pfizer vs. the Counterfeiters Its suit against an Indian man alleging that he sold fake Viagra shows how hard it is to shut down online drug marketers. |
The Motley Fool
April 22, 2011
Sean Williams |
Pharma's Most Perilous Pipelines Patent expirations expose weaknesses for these Wall Street darlings. |
